-
People and CultureFlexibility at Novartis: Janneke van der Kamp
Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.
People and Culture -
People and CultureFlexibility at Novartis: Christine Sturchler and Aileen Wrynn
Sturchler and Wrynn explain why their job-sharing experience was one of the most successful and energizing periods of their careers.
People and Culture -
DiscoveryToward improving the health and longevity of transplanted organs
Novartis researchers are working to extend the life of organ transplants
Discovery -
DiscoveryWomen in Science: Shannon Campbell
How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.
Discovery -
DiscoveryInvestigating the myopia mystery
Two scientists from Basel are trying to shed light on why myopia is impacting more and more people.
Discovery -
DiscoveryCancer research drives breast cancer treatment forward
Novartis team perseveres to develop more personalized approach to breast cancer therapy.
Discovery -
DiscoveryRespiratory clinical trials: Putting patients at the heart of research
All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.
Discovery -
DiscoveryWomen in Science: Sandrine Piret-Gérard
Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.
Discovery -
Access to HealthcareAsian health experts call for final push to wipe out deadliest form of malaria
The most lethal strain could be eliminated by 2030, but major hurdles remain.
Access to Healthcare -
DiscoveryCounting on combos for complex liver diseases
The best treatment for multifaceted diseases like NASH may be combinations of drugs.
Discovery -
DiscoveryBringing gene therapy into focus
Dr. Botond Roska says we should keep our eyes on gene therapy.
Discovery -
From Our LabsWhat goes wrong with the window to the soul in glaucoma?
Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
From Our Labs